Wei-Gang Fang

Title: Innovations of Wei-Gang Fang in Antineoplastic Agents

Introduction

Wei-Gang Fang is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antineoplastic agents. With a total of 2 patents, his work focuses on innovative treatments for hormone-independent cancers.

Latest Patents

Wei-Gang Fang's latest patents include the use of purinergic receptor agonists as antineoplastic agents. This invention is directed towards a pharmaceutical composition that contains an effective amount of adenosine or an adenosine analog or derivative. It is particularly useful in the treatment of hormone-independent cancers, such as prostate cancer. The invention also encompasses diagnostic uses of these compounds to determine effective treatment regimes for specific tumors. Additionally, it includes a process for screening new, therapeutically useful analogs of these compounds and their use in facilitating the extraction of intracellular components.

Career Highlights

Wei-Gang Fang works for the United States of America as represented by the Department of Health. His role in this esteemed organization highlights his commitment to advancing medical research and innovation.

Collaborations

Throughout his career, Wei-Gang Fang has collaborated with notable colleagues, including Jane B Trepel and Farzaneh Pirnia. These collaborations have likely contributed to the success and impact of his inventions.

Conclusion

Wei-Gang Fang's innovative work in the field of antineoplastic agents demonstrates his dedication to improving cancer treatment options. His contributions are significant in the ongoing fight against hormone-independent cancers.